Categories
Archives
Tag Archives: hearticellgram-
Stem Cell Therapy Market in Asia-Pacific to 2018 – Commercialization Supported by Favorable Government Policies …
NEW YORK, April 24, 2013 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue: Stem Cell Therapy Market in Asia-Pacific to 2018 – Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity http://www.reportlinker.com/p01075729/Stem-Cell-Therapy-Market-in-Asia-Pacific-to-2018—Commercialization-Supported-by-Favorable-Government-Policies-Strong-Pipeline-and-Increased-Licensing-Activity.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biological_Therapy Stem Cell Therapy Market in Asia-Pacific to 2018 – Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity Summary GBI Research, the leading business intelligence provider, has released its latest research “Stem Cell Therapy Market in Asia-Pacific to 2018 – Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity”. The report provides an in-depth analysis on stem cell research and development in India, China, Japan, South-Korea and Singapore Continue reading
Posted in Stem Cell Research
Tagged asia-, biotechnology, cerecellgram, china, compound-annual, country, generated, hearticellgram-, india, japan-, leading, molecules, pipeline, therapy-market, york
Comments Off
Stem Cell Treatment Approved For Heart Attack Victims In South Korea
A stem cell treatment for heart attack victims has been approved in South Korea, five years after stem cell research was put on hold due to a cloning research scandal. The Korea Food and Drug Administration (KFDA) approved Hearticellgram-AMI for treatment, developed by FCB-Pharmicell Continue reading
Posted in Stem Cell Research
Tagged after-stem, approval-, been-approved, cell-research, five-years, hearticellgram-, hold-due, new-push, put-stem, south-korea, stem-cell, the-field, victims-has
Comments Off
New South Korea Adult Stem Cell Therapy Breakthrough
Share The Korea Food and Drug Administration (KFDA) has approved the sale of Hearticellgram-AMI, a stem cell therapy for acute myocardial infarction, commonly known as heart attack, which was derived from experimentation … Continue reading
Posted in Stem Cell Treatment
Tagged approved-the-sale, commonly-known, has-approved, heart-attack, hearticellgram-, kfda, korea-food, sale, stem-cell
Comments Off
S Korea Approves Stem Cell Treatment For Heart Attack Victims
Five years after South Korea’s scientific reputation was shattered by a cloning research scandal, the country has approved stem cell medication for heart attack victims. South Korea put stem cell research on hold after Hwang Woo-Suk was found guilty of fraud for his work in the field in 2005 Continue reading
Posted in Stem Cell Research
Tagged a-put-stem, cell-research, country, field, heart-attack, hearticellgram-, hwang-woo-, korea-, medication-for, south-korea, treatment
Comments Off